Nasdaq, Inc. Peer Comparison
Metric | Value | Ranking | |||||||
---|---|---|---|---|---|---|---|---|---|
Market Cap | $45.3 Billion | 6/7 | SPGI $155.7B |
MCO $86.2B |
ICE $85.6B |
CME $83.9B |
MSCI $48.0B |
NDAQ $45.3B |
FDS $17.6B |
Gross Margin | 21% | 7/7 | MSCI 95% |
ICE 75% |
SPGI 70% |
CME 66% |
FDS 54% |
MCO 37% |
NDAQ 21% |
Profit Margin | 16% | 7/7 | CME 56% |
MSCI 39% |
MCO 29% |
SPGI 27% |
FDS 26% |
ICE 22% |
NDAQ 16% |
EBITDA margin | 0% | 7/7 | CME 62% |
SPGI 48% |
MSCI 42% |
ICE 35% |
FDS 34% |
MCO 25% |
NDAQ 0% |
Quarterly Revenue | $1.9 Billion | 3/7 | SPGI $3.6B |
ICE $3.0B |
NDAQ $1.9B |
MCO $1.8B |
CME $1.6B |
MSCI $724.7M |
FDS $568.7M |
Quarterly Earnings | $306.0 Million | 5/7 | SPGI $971.0M |
CME $879.4M |
ICE $657.0M |
MCO $534.0M |
NDAQ $306.0M |
MSCI $280.9M |
FDS $150.0M |
Quarterly Free Cash Flow | $978.0 Million | 2/7 | SPGI $1.4B |
NDAQ $978.0M |
MCO $874.0M |
ICE $819.0M |
MSCI $415.0M |
FDS $60.5M |
CME -$0 |
Trailing 4 Quarters Revenue | $7.0 Billion | 3/7 | SPGI $13.8B |
ICE $11.2B |
NDAQ $7.0B |
MCO $6.9B |
CME $6.0B |
MSCI $2.8B |
FDS $2.2B |
Trailing 4 Quarters Earnings | $959.0 Million | 6/7 | SPGI $3.6B |
ICE $3.0B |
NDAQ $1.9B |
MCO $1.8B |
CME $1.6B |
MSCI $724.7M |
FDS $568.7M |
Quarterly Earnings Growth | 4% | 6/7 | MCO 37% |
SPGI 31% |
ICE 21% |
CME 17% |
MSCI 8% |
NDAQ 4% |
FDS 1% |
Annual Earnings Growth | -12% | 6/7 | FDS 57% |
SPGI 56% |
MCO 32% |
MSCI 21% |
CME 10% |
NDAQ -12% |
ICE -17% |
Quarterly Revenue Growth | 31% | 1/7 | NDAQ 31% |
ICE 25% |
MCO 23% |
CME 18% |
MSCI 16% |
SPGI 16% |
FDS 5% |
Annual Revenue Growth | 22% | 1/7 | NDAQ 22% |
ICE 19% |
MCO 16% |
MSCI 13% |
CME 12% |
SPGI 11% |
FDS 4% |
Cash On Hand | $308.0 Million | 6/7 | MCO $2.6B |
CME $2.3B |
ICE $2.0B |
SPGI $1.7B |
MSCI $501.0M |
NDAQ $308.0M |
FDS $289.2M |
Short Term Debt | $499.0 Million | 4/7 | ICE $2.6B |
MCO $802.0M |
CME $749.7M |
NDAQ $499.0M |
FDS $93.9M |
SPGI $4.0M |
MSCI -$0 |
Long Term Debt | $9.8 Billion | 3/7 | ICE $18.9B |
SPGI $11.4B |
NDAQ $9.8B |
MCO $7.1B |
MSCI $4.6B |
CME $2.7B |
FDS $1.5B |
PE | 47.25 | 1/7 | NDAQ 47.25 |
SPGI 43.84 |
MCO 43.05 |
MSCI 39.74 |
ICE 35.25 |
FDS 32.69 |
CME 24.66 |
PS | 6.46 | 7/7 | MSCI 17.11 |
CME 13.87 |
MCO 12.50 |
SPGI 11.31 |
FDS 7.90 |
ICE 7.65 |
NDAQ 6.46 |
PB | 4.09 | 3/7 | MCO 21.20 |
FDS 8.84 |
NDAQ 4.09 |
SPGI 4.06 |
ICE 3.14 |
CME 2.97 |
MSCI 0.00 |
PC | 147.10 | 1/7 | NDAQ 147.10 |
MSCI 95.74 |
SPGI 91.82 |
FDS 60.89 |
ICE 42.85 |
CME 36.11 |
MCO 32.64 |
Liabilities to Equity | 1.76 | 4/7 | ICE 3.96 |
CME 3.88 |
MCO 3.00 |
NDAQ 1.76 |
FDS 1.03 |
SPGI 0.65 |
MSCI 0.00 |
ROA | 0.03 | 5/7 | MSCI 22% | MCO 13% | FDS 13% | SPGI 6% | NDAQ 3% | ICE 2% | CME 2% |
ROE | 0.09 | 5/7 | MCO 51% |
FDS 27% |
CME 12% |
SPGI 10% |
NDAQ 9% |
ICE 9% |
MSCI -161% |
Current Ratio | 1.57 | 3/7 | SPGI 2.75 |
FDS 1.97 |
NDAQ 1.57 |
MCO 1.35 |
CME 1.26 |
ICE 1.25 |
MSCI 0.88 |
Quick Ratio | 0.02 | 5/7 | NDAQ 47.25 |
SPGI 43.84 |
MCO 43.05 |
MSCI 39.74 |
ICE 35.25 |
FDS 32.69 |
CME 24.66 |
Long Term Debt to Equity | 0.88 | 2/7 | MCO} 1.82 |
NDAQ} 0.88 |
FDS} 0.73 |
ICE} 0.69 |
SPGI} 0.34 |
CME} 0.09 |
MSCI} -6.14 |
Debt to Equity | 0.93 | 2/7 | MCO 2.03 |
NDAQ 0.93 |
ICE 0.79 |
FDS 0.78 |
SPGI 0.34 |
CME 0.12 |
MSCI -6.14 |
Burn Rate | 1.47 | 2/7 | ICE 2.65 |
NDAQ 1.47 |
SPGI -3.30 |
CME -3.97 |
FDS -4.24 |
MSCI -5.19 |
MCO -54.30 |
Cash to Cap | 0.01 | 5/7 | CME 0.03 |
MCO 0.03 |
ICE 0.02 |
FDS 0.02 |
NDAQ 0.01 |
MSCI 0.01 |
SPGI 0.01 |
CCR | 3.20 | 1/7 | NDAQ 3.20 |
MCO 1.64 |
MSCI 1.48 |
SPGI 1.45 |
ICE 1.25 |
FDS 0.40 |
CME |
EV to EBITDA | -11051.43 | 7/7 | MCO} 200.67 |
MSCI} 171.23 |
ICE} 100.42 |
FDS} 98.62 |
SPGI} 95.85 |
CME} 86.61 |
NDAQ} -11051.43 |
EV to Revenue | 7.87 | 7/7 | MSCI 18.58 |
CME 14.06 |
MCO 13.27 |
SPGI 12.02 |
ICE 9.40 |
FDS 8.46 |
NDAQ 7.87 |